baccaratpink| CITIC Construction Investment: The clinical trial results of domestic innovative pharmaceutical companies at the 2024 ASCO Conference are outstanding, and oncology drugs show BIC potential

News summary

CITIC Construction Investment focuses on the 2024 ASCO Conferencebaccaratpink, domestic innovative pharmaceutical companies have demonstrated innovation and clinical effects in the field of oncology drugs. Many products have BIC potential, and subsequent progress is worthy of market expectations.

Newsletter text

CITIC Construction Investment pays attention to the progress of domestic innovative pharmaceutical companies at the 2024 ASCO Conference

At the 2024 ASCO conference, many domestic innovative pharmaceutical companies announcedbaccaratpinkThe latest results of its clinical trials were reviewed. CITIC Construction Investment analysis pointed out that these pharmaceutical companies have performed particularly well in the field of cancer treatment, and the types of drugs involved include monoclonal antibodies, dual antibodies and ADCs, showing extremely high innovation and clinical effects. China's innovative pharmaceutical companies continue to invest in the field of cancer treatment. Many products have shown the potential to become the best drugs in their class, and future clinical trial results are highly anticipated.

Tags:

Prev: tronarcade| China's e-commerce dominates South Korea's overseas shopping consumption: China surpassed the United States for the first time, reaching 17.4 billion yuan
Next: casinoextreme1000freespins2022| Ethereum ETH: Intraday increase of 1.58%, breaking through the US$3800 mark